In this issue:
Lenalidomide + R-CHOP in previously untreated ABC-type DLBCL
Lenalidomide + R-CHOP in newly diagnosed DLBCL
Lenalidomide + SC R-MiniCHOP in elderly DLBCL
Sequencing of blinatumomab and inotuzumab ozogamicin in R/R ALL
Sequencing of blinatumomab in R/R B-cell precursor ALL
5-azacytidine + romidepsin in PTCL
Chemotherapy or alloHSCT in high-risk Ph–negative ALL
Ibrutinib for MCL at first relapse
Management of TKI-treated CML during pregnancy
Prophylactic high-dose MTX in high-risk DLBCL
Please login below to download this issue (PDF)